ArticleFrontiers in cardiovascular medicine2025
Construction and validation of a prediction model for 90-day readmission risk in patients with chronic heart failure.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chronic heart failure (CHF) is associated with high morbidity and mortality rates, which is not curable currently, resulting in an increasing risk of readmission and imposing a considerable burden on healthcare systems. Predictive modeling is a critical tool for guiding the clinical management of CHF. 90-day is a crucial time point for readmission risk assessment in patients with CHF. However, there is a lack of risk factor exploration, as well as predictive modeling for 90-day readmission risk in these patients. The aim of this study is to identify prognostic risk biomarkers and develop a novel prediction model for 90-day readmission for patients with CHF. Methods: 542 CHF patients hospitalized at the Department of Cardiology, the Fourth Affiliated Hospital of Zhejiang University were randomly split into training ( Results: Of the included 542 patients, the readmission rates were 18.7% and 19.1% in 90-day follow-up in the training and validation cohort respectively. Five variables, including cardiac troponin (cTn), fasting blood glucose (FBG), serum sodium, estimated glomerular filtration rate (eGFR), neutrophil (NEU) showed the strongest correlation with 90-day readmission according to LASSO regression. These selected variables were then combined into a novel prediction model, with an AUC of 0.746 [95% (confidence interval) CI: 0.685-0.808] in the training cohort and 0.705 (95% CI: 0.605-0.804) in the validation cohort. Conclusions: Our findings suggest that a predictive model incorporating the variables of cTn, FBG, serum sodium, eGFR and NEU demonstrating a good predictive ability for 90-day readmission risk in patients with CHF, which can aid clinicians in clinical decisions and personalized management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.